Literature DB >> 16088616

Respiratory complications of amyotrophic lateral sclerosis.

Joshua O Benditt1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with no known cure. Involvement of muscles of the respiratory system, the inspiratory, expiratory, and upper airway muscles, is the major cause of morbidity and mortality. Dyspnea, swallowing difficulties, sialorrhea, and impaired cough are all symptoms that can be palliated with pharmacological and nonpharmacological methods. Noninvasive positive pressure ventilation (NPPV) in particular is a technique to assist ventilation that not only relieves dyspnea and ameliorates respiratory failure but may also extend the lives of patients with this disease. It should be offered to all ALS patients with a forced vital capacity of less than 50%.

Entities:  

Year:  2002        PMID: 16088616     DOI: 10.1055/s-2002-33032

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  9 in total

1.  Under-recognized primary spontaneous pneumothorax in ALS: a multicenter retrospective study.

Authors:  Jin-Sung Park; Young Woo Do; Jin-Mo Park; Hung Youl Seok; Donghwi Park
Journal:  Neurol Sci       Date:  2019-07-02       Impact factor: 3.307

Review 2.  Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.

Authors:  Ashley A Waito; Teresa J Valenzano; Melanie Peladeau-Pigeon; Catriona M Steele
Journal:  Dysphagia       Date:  2017-06-29       Impact factor: 3.438

3.  Characteristics of impaired voluntary cough function in individuals with amyotrophic lateral sclerosis.

Authors:  Lauren C Tabor-Gray; Alessandra Gallestagui; Terrie Vasilopoulos; Emily K Plowman
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-01-17       Impact factor: 4.092

4.  Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes.

Authors:  Richard B Berry; Alejandro Chediak; Lee K Brown; Jonathan Finder; David Gozal; Conrad Iber; Clete A Kushida; Timothy Morgenthaler; James A Rowley; Sally L Davidson-Ward
Journal:  J Clin Sleep Med       Date:  2010-10-15       Impact factor: 4.062

5.  Predictors of Peak Expiratory Cough Flow in Individuals with Amyotrophic Lateral Sclerosis.

Authors:  Lauren Tabor Gray; Kasey L McElheny; Terrie Vasilopoulos; James Wymer; Barbara K Smith; Emily K Plowman
Journal:  Dysphagia       Date:  2022-08-05       Impact factor: 2.733

6.  Associations between laryngeal and cough dysfunction in motor neuron disease with bulbar involvement.

Authors:  Deanna Britton; Joshua O Benditt; Albert L Merati; Robert M Miller; Cara E Stepp; Louis Boitano; Amanda Hu; Marcia A Ciol; Kathryn M Yorkston
Journal:  Dysphagia       Date:  2014-07-19       Impact factor: 3.438

Review 7.  Diaphragmatic Neurophysiology and Respiratory Markers in ALS.

Authors:  Mamede de Carvalho; Michael Swash; Susana Pinto
Journal:  Front Neurol       Date:  2019-02-21       Impact factor: 4.003

8.  Effects of nasal high flow on nocturnal hypercapnia, sleep, and sympathovagal balance in patients with neuromuscular disorders.

Authors:  Anna Christina Meyer; Jens Spiesshoefer; Nina Christina Siebers; Anna Heidbreder; Christian Thiedemann; Hartmut Schneider; Andrew T Braun; Winfried Randerath; Peter Young; Michael Dreher; Matthias Boentert
Journal:  Sleep Breath       Date:  2020-12-02       Impact factor: 2.816

9.  Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency.

Authors:  Pierluigi Carratù; Lucia Spicuzza; Anna Cassano; Mauro Maniscalco; Felice Gadaleta; Donato Lacedonia; Cristina Scoditti; Ester Boniello; Giuseppe Di Maria; Onofrio Resta
Journal:  Orphanet J Rare Dis       Date:  2009-03-10       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.